OUR MISSION
We are a technology company dedicated to improving eyecare through innovations. Our goal is bring first-of-its-kind treatment modalities to treat eye diseases that lack an effective therapy at present. We use a multidisciplinary approach to develop new therapeutics through proof-of-concept design iterations, modelling and feasibility studies, pre-clinical safety studies that leads to clinical trials or clinical applications.
OUR FOCUS
We draw on our engineering and clinical experience in ophthalmology to develop new therapies to treat eye diseases that lack an effective treatment. Products currently under development include treatments for central serous chorioretinopathy, myopic degeneration, myopic tractional maculopathy, tractional retinal detachment and proliferative vitreoretinopathy.
OUR APPROACH
Using a multidisciplinary approach, we aim to bring revolutionary therapies to treat eye diseases currently without effective treatment. Like an octagon, we look at the clinical problems from multiple different angles and aim to apply a fusion of technologies to solve these difficult clinical problems in eyecare.
"When something is important enough, you do it even if the odds are not in your favor"